# Resveratrol Blood Glucose Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/resveratrol-blood-glucose-randomized-trial-evidence-review
Category: evidence-review
Summary: Resveratrol Blood Glucose Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass 
Last reviewed: 2026-08-13
Reviewed by: Migaku Evidence Review
# Resveratrol Blood Glucose Randomized Trial: What the Evidence Says

## Quick Answer

Resveratrol Blood Glucose Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review | systematic review | 1 | 2026-05-26 | 10.3390/molecules31111837 |
| Antioxidants in Menopausal Transition and Male Late-Onset Hypogonadism for the Prevention of Diabetes | narrative review | 3 | 2026-05-24 | 10.3390/antiox15060659 |

## What The Sources Report

- Obesity, defined as excessive accumulation of adipose tissue, is strongly associated with metabolic complications, including hypertension, dyslipidemia, and type 2 diabetes. [Gazda Patrycja (2026); evidence level 1]
- Chronic low-grade inflammation associated with obesity contributes to metabolic dysfunction through the increased production of pro-inflammatory cytokines and adipocytokines. [Gazda Patrycja (2026); evidence level 1]
- Experimental data and clinical studies highlight the cardiometabolic changes associated with gonadal aging and reproductive hormones' withdrawal. [Karaflou Maria (2026); evidence level 3]
- Body composition changes with increased fat mass and abdominal fat distribution are associated with insulin resistance and subsequent diabetes in older ages. [Karaflou Maria (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For resveratrol blood glucose randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Gazda Patrycja (2026). The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review. DOI: 10.3390/molecules31111837. PMCID: PMC13258050. PMID: 42280140. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13258050/
- Karaflou Maria (2026). Antioxidants in Menopausal Transition and Male Late-Onset Hypogonadism for the Prevention of Diabetes. DOI: 10.3390/antiox15060659. PMCID: PMC13296154. PMID: 42351965. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13296154/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.